# US Bone Density Test Market

> United States Bone Density Test Market Research Report By Type (DXA Systems, Peripheral Bone Densitometers, Radiographic absorptiometry scanners, Quantitative ultrasound scanners) By End-User (Hospitals and Specialty Clinics, Diagnostic and Imaging Centers) By Application (Osteoporosis Diagnosis, Osteopenia Diagnosis, Cystic Fibrosis Diagnosis, Body Composition Measurement, Rheumatoid Arthritis Diagnosis) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 2.64%
- **2024:** $ 298.9 Million
- **2025:** $ 306.79 Million
- **2035:** $ 398 Million
- **Key Players:** Hologic (US), GE Healthcare (US), Siemens Healthineers (DE), Philips (NL), Fujifilm (JP), Canon Medical Systems (JP), Medtronic (IE), Agfa-Gevaert (BE), Radiology Partners (US)

**Report ID:** MRFR/LS/17770-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-bone-density-test-market-19317

---

## Market Summary

## US Bone Density Test Market Highlighted Trends & Dynamics

The US Bone Density Test Market grows as more people learn about osteoporosis, better testing tools come out, and preventative health care becomes more popular. Here are some important facts about how this market works:

Bone density testing are needed as the US population rises. Over-50s are more likely to develop osteoporosis, therefore assess their bone density to prevent fractures and other bone disorders. The business of measuring bone density is changing because of new picture technology. Two new ways to check your bone health are peripheral DXA and quantitative ultrasound.

To help people get better care, more and more bone density tests are being done right where they are. More tests and early diagnoses of bone health are being done thanks to movable tools and technology that make point-of-care bone density tests possible.

Women who have gone through puberty, people with a history of the disease in their family, and people who use drugs or have health problems that hurt bones are more likely to get osteoporosis. Screening groups for people who are at high risk recommend bone density tests.

Injury risk relies on bone density. These diagnostics tell physicians which people are most prone to break bones. They may then give patients drugs, lifestyle adjustments, or vitamin supplements to prevent bone breakage.

To treat osteoporosis, bone density examinations are crucial. Doctors utilize bone density testing in bone health programs to prevent, detect, and treat osteoporosis. Insurance and payment can make it harder or easier to get bone density tests. It's easier to get bone density tests now that there are clear ways to get them paid for.

Diagnostic centers and health care workers need to work together to make it easy for a lot of people to get bone density tests. This link means that both general care offices and expert imaging sites have places where tests can be done.

Patients who learn about and fight for bone density tests are the ones who make them popular. More people are getting tested and getting involved because of programs that teach people about osteoporosis and bone health and because diagnostic tests are easier to get.

When it comes to bone density tests, competition drives new research and development to make tools and methods better. The business stays competitive by coming up with new ways to check bone health and work on school projects together.

## Market Drivers

### Growing Aging Population

The increasing aging population in the US is a primary driver for the bone density-test market. As individuals age, the risk of osteoporosis and related bone disorders escalates, necessitating regular screening. According to the US Census Bureau, by 2030, all baby boomers will be over 65 years old, leading to a significant rise in the demand for bone density testing. This demographic shift indicates a potential market growth of approximately 25% in the next five years. Healthcare providers are likely to prioritize preventive measures, including bone density tests, to manage osteoporosis effectively. Consequently, the bone density-test market is expected to expand as healthcare systems adapt to the needs of an older population, emphasizing the importance of early detection and intervention.

### Focus on Preventive Healthcare

The growing focus on preventive healthcare is a vital driver for the bone density-test market. As healthcare systems shift towards preventive strategies, the importance of early detection of osteoporosis becomes increasingly recognized. This trend is reflected in the implementation of screening guidelines by organizations such as the US Preventive Services Task Force, which recommends bone density testing for certain populations. The bone density-test market is likely to benefit from this proactive approach, as more individuals become aware of the need for regular screenings. Additionally, public health campaigns aimed at educating the population about bone health may further stimulate demand for testing services. This emphasis on prevention could lead to a market expansion of around 22% in the next few years, as healthcare providers prioritize early intervention to reduce the burden of osteoporosis.

### Increased Healthcare Expenditure

Rising healthcare expenditure in the US is another crucial driver for the bone density-test market. With healthcare spending projected to reach $6 trillion by 2027, there is a growing emphasis on preventive care and early diagnosis. This trend is likely to enhance the adoption of bone density testing as part of routine health assessments, particularly for at-risk populations. The bone density-test market stands to benefit from increased funding for osteoporosis screening programs, which may lead to a higher volume of tests conducted annually. Furthermore, insurance coverage for preventive services is expanding, making bone density tests more accessible to patients. This financial support could potentially increase the market size by 15% over the next few years, as more individuals seek out these essential diagnostic services.

### Rising Incidence of Osteoporosis

The rising incidence of osteoporosis in the US population is a significant driver for the bone density-test market. Recent studies indicate that approximately 10 million Americans are currently diagnosed with osteoporosis, with an additional 44 million at risk of developing the condition. This alarming trend underscores the necessity for widespread screening and early intervention, which the bone density-test market aims to address. As awareness of osteoporosis grows, healthcare providers are likely to recommend regular bone density tests, particularly for women over 65 and men over 70. This increasing prevalence may lead to a projected market growth of around 20% in the coming years, as more individuals seek testing to monitor their bone health and prevent fractures.

### Advancements in Diagnostic Technology

Advancements in diagnostic technology are transforming the bone density-test market. Innovations such as dual-energy X-ray absorptiometry (DXA) and quantitative computed tomography (QCT) are enhancing the accuracy and efficiency of bone density assessments. These technologies allow for more precise measurements of bone mineral density, which is crucial for diagnosing osteoporosis. The bone density-test market is likely to see increased adoption of these advanced testing methods, as healthcare providers seek to improve patient outcomes. Furthermore, the integration of artificial intelligence in imaging analysis may streamline the testing process, potentially increasing the number of tests performed annually. This technological evolution could contribute to a market growth rate of approximately 18% over the next five years, as healthcare facilities invest in state-of-the-art diagnostic equipment.

## Future Outlook

The [Bone Density Test Market](https://www.marketresearchfuture.com/reports/bone-density-test-market-4766) is projected to grow at a 2.64% CAGR from 2025 to 2035, driven by increasing osteoporosis prevalence, technological advancements, and rising healthcare awareness.

**New opportunities:**

- Development of portable bone density testing devices for home use. Integration of AI analytics in bone density assessment tools. Expansion of telehealth services for remote bone health consultations.

By 2035, the market is expected to achieve robust growth, reflecting advancements in technology and increased consumer demand.

## Segment Insights

### By Type: DXA Systems (Largest) vs. Peripheral Bone Densitometers (Fastest-Growing)

In the US bone density-test market, DXA systems hold the largest market share due to their established presence and widespread acceptance among healthcare providers. These systems are considered the gold standard for measuring bone mineral density and provide accurate results for diagnosing osteoporosis and other bone-related conditions. On the other hand, peripheral bone densitometers have begun to gain traction owing to their portability and ease of use, making them popular in outpatient settings and among patients who seek more accessible testing options.

Growth trends in the segment show a rising demand for both DXA systems and peripheral bone densitometers. The aging population and increased awareness of osteoporosis have driven the need for regular bone density testing. Furthermore, technological advancements and innovations in imaging techniques are facilitating the enhancement and accessibility of these tests, leading to an expansion in end-user applications and a growing market presence.

DXA Systems (Dominant) vs. Peripheral Bone Densitometers (Emerging)

DXA systems are recognized as the dominant force in the US bone density-test market due to their comprehensive capabilities and detailed assessment of bone health. These systems utilize dual-energy X-ray absorptiometry technology, allowing for precise measurements of bone mineral density, which is critical for diagnosing conditions like osteoporosis. In contrast, peripheral bone densitometers represent an emerging segment, offering advantages such as portability and cost-effectiveness. These devices are typically used in non-hospital settings, appealing to a broader audience by providing convenient and efficient bone density assessments. Both segments are crucial in addressing the diverse needs of healthcare providers and patients within the market.

### By Application: Osteoporosis Diagnosis (Largest) vs. Osteopenia Diagnosis (Fastest-Growing)

In the US bone density-test market, Osteoporosis Diagnosis holds the largest market share among the application segments, reflecting a significant portion of the overall demand for bone density testing services. Following closely is Osteopenia Diagnosis, which, while smaller in market share, is rapidly gaining traction as awareness and utilization of bone density tests increase, particularly among aging populations and those at risk for various bone-related conditions.

Growth trends indicate a positive trajectory for the application segments, driven by a rising prevalence of osteoporosis and the increasing awareness of bone health among consumers. The expansion of health coverage and enhanced screening recommendations have also propelled the demand for tests in these areas, positioning Osteopenia Diagnosis as the fastest-growing segment due to its critical role in early intervention and prevention strategies in bone health management.

Osteoporosis Diagnosis (Dominant) vs. Osteopenia Diagnosis (Emerging)

Osteoporosis Diagnosis remains the dominant application segment in the US bone density-test market, primarily due to the higher incidence and awareness of osteoporosis among adults, leading to increased testing and preventative measures. Rapid advancements in diagnostic technologies and treatment options further contribute to its leading status. In contrast, Osteopenia Diagnosis is emerging as a vital segment, reflecting growing recognition of bone health concerns prior to osteoporosis. This segment appeals to younger demographics and those with risk factors, as health practitioners emphasize proactive management of bone density to prevent further complications. Together, these segments underscore the importance of comprehensive bone health assessments and targeted interventions.

### By End-User: Hospitals and Specialty Clinics (Largest) vs. Diagnostic and Imaging Centers (Fastest-Growing)

In the US bone density-test market, Hospitals and Specialty Clinics dominate the end-user segment, holding a significant share due to their comprehensive healthcare services and access to advanced diagnostic equipment. These facilities often integrate bone density testing as part of routine health assessments, attracting a vast patient base that contributes to their considerable market share.

However, Diagnostic and Imaging Centers are emerging as the fastest-growing segment, driven by advances in imaging technologies and increasing awareness of bone health. The rising prevalence of osteoporosis and related conditions has spurred demand for specialized diagnostic services, positioning these centers for rapid expansion in the coming years.

Hospitals and Specialty Clinics (Dominant) vs. Diagnostic and Imaging Centers (Emerging)

Hospitals and Specialty Clinics play a dominant role in the US bone density-test market owing to their established infrastructure and multidisciplinary approach to patient care. They provide a wide range of services, including bone health assessments, which are essential for early diagnosis and management of osteoporosis. These facilities also benefit from higher patient volumes and strong referral networks. Conversely, Diagnostic and Imaging Centers are positioned as an emerging segment, characterized by their focus on specialized diagnostic services. These centers provide quick and accurate bone density testing with a greater emphasis on patient convenience. Their rapid growth is fueled by technological advancements and a shift towards non-invasive diagnostic procedures that cater to the increasing consumer demand for bone health monitoring.

## Competitive Benchmarking

The bone density-test market is characterized by a competitive landscape that is increasingly shaped by technological advancements and strategic collaborations. Key growth drivers include the rising prevalence of osteoporosis and other bone-related disorders, alongside an aging population that necessitates regular screening. Major players such as Hologic (US), GE Healthcare (US), and Siemens Healthineers (DE) are at the forefront, each adopting distinct strategies to enhance their market positioning. Hologic (US) focuses on innovation in imaging technologies, while GE Healthcare (US) emphasizes partnerships to expand its product offerings. Siemens Healthineers (DE) is investing in digital transformation to streamline operations and improve patient outcomes, collectively shaping a dynamic competitive environment.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several key players exerting considerable influence. This fragmentation allows for niche players to emerge, yet the collective strength of major companies like Philips (NL) and Fujifilm (JP) ensures that competition remains robust and innovation-driven.

In October  Hologic (US) announced a strategic partnership with a leading telehealth provider to integrate remote monitoring capabilities into its bone density testing solutions. This move is significant as it aligns with the growing trend towards telemedicine, potentially increasing patient access to essential diagnostic services and enhancing the company's market reach. The integration of telehealth solutions may also improve patient compliance and follow-up, which are critical in managing bone health.

In September  GE Healthcare (US) launched a new AI-driven software platform designed to enhance the accuracy of bone density assessments. This development is crucial as it not only positions GE Healthcare (US) as a leader in technological innovation but also addresses the increasing demand for precision in diagnostic imaging. The incorporation of AI could lead to improved patient outcomes and operational efficiencies, thereby strengthening the company's competitive edge.

In August  Siemens Healthineers (DE) expanded its product portfolio by acquiring a small tech firm specializing in advanced imaging algorithms. This acquisition is indicative of a broader trend where established companies seek to bolster their technological capabilities through strategic acquisitions. By enhancing its imaging solutions, Siemens Healthineers (DE) is likely to improve its market share and respond effectively to evolving customer needs.

As of November  current competitive trends in the bone density-test market are heavily influenced by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming increasingly vital, enabling companies to leverage complementary strengths and enhance their service offerings. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition towards innovation, technological advancements, and supply chain reliability. This transition underscores the importance of not only meeting current market demands but also anticipating future trends in healthcare delivery.

## Report Scope

| MARKET SIZE 2024 | 298.9(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 306.79(USD Million) |
| MARKET SIZE 2035 | 398.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 2.64% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Hologic (US), GE Healthcare (US), Siemens Healthineers (DE), Philips (NL), Fujifilm (JP), Canon Medical Systems (JP), Medtronic (IE), Agfa-Gevaert (BE), Radiology Partners (US) |
| Segments Covered | Type, Application, End-User |
| Key Market Opportunities | Integration of advanced imaging technologies enhances accuracy in the bone density-test market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive growth in the bone density-test market, enhancing diagnostic accuracy and accessibility. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the market valuation of the US bone density-test market in 2024?**
A: The market valuation was $298.9 Million in 2024.

**Q: What is the projected market valuation for the US bone density-test market in 2035?**
A: The projected valuation for 2035 is $398.0 Million.

**Q: What is the expected CAGR for the US bone density-test market during the forecast period 2025 - 2035?**
A: The expected CAGR is 2.64% during the forecast period 2025 - 2035.

**Q: Which companies are considered key players in the US bone density-test market?**
A: Key players include Hologic, GE Healthcare, Siemens Healthineers, Philips, Fujifilm, Canon Medical Systems, Medtronic, Agfa-Gevaert, and Radiology Partners.

**Q: What segment had the highest valuation in the US bone density-test market in 2024?**
A: DXA Systems had the highest valuation at $150.0 Million to $200.0 Million.

**Q: What is the valuation range for Peripheral Bone Densitometers in the US bone density-test market?**
A: The valuation range for Peripheral Bone Densitometers is $80.0 Million to $100.0 Million.

**Q: Which application segment is projected to have the highest valuation in the US bone density-test market?**
A: Osteoporosis Diagnosis is projected to have the highest valuation, ranging from $120.0 Million to $160.0 Million.

**Q: What is the valuation range for Body Composition Measurement in the US bone density-test market?**
A: The valuation range for Body Composition Measurement is $50.0 Million to $70.0 Million.

**Q: Which end-user segment had a comparable valuation to Diagnostic and Imaging Centers in 2024?**
A: Hospitals and Specialty Clinics had a comparable valuation, ranging from $150.0 Million to $200.0 Million.

**Q: What is the projected growth trend for the US bone density-test market by 2035?**
A: The market is expected to grow steadily, reaching a valuation of $398.0 Million by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-bone-density-test-market-19317*